17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts

David B. Solit, Fuzhong F. Zheng, Maria Drobnjak, Pamela N. Münster, Brian Higgins, David Verbel, Glenn Heller, William Tong, Carlos Cordon-Cardo, David B. Agus, Howard I. Scher, Neal Rosen

Research output: Contribution to journal › Article › peer-review

439 Scopus citations

Fingerprint

Dive into the research topics of '17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences